Publications in collaboration with researchers from Technical University Munich (1)

2022

  1. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 12, pp. 1703-1715